JP2020531495A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020531495A5 JP2020531495A5 JP2020510543A JP2020510543A JP2020531495A5 JP 2020531495 A5 JP2020531495 A5 JP 2020531495A5 JP 2020510543 A JP2020510543 A JP 2020510543A JP 2020510543 A JP2020510543 A JP 2020510543A JP 2020531495 A5 JP2020531495 A5 JP 2020531495A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- onecut2
- isomer
- expression
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*COc(c(O)c(CC(NCC(NO)=O)=O)cc1)c1O Chemical compound C*COc(c(O)c(CC(NCC(NO)=O)=O)cc1)c1O 0.000 description 3
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762548879P | 2017-08-22 | 2017-08-22 | |
| US62/548,879 | 2017-08-22 | ||
| PCT/US2018/047569 WO2019040647A1 (en) | 2017-08-22 | 2018-08-22 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020531495A JP2020531495A (ja) | 2020-11-05 |
| JP2020531495A5 true JP2020531495A5 (https=) | 2021-10-07 |
| JP7293194B2 JP7293194B2 (ja) | 2023-06-19 |
Family
ID=65440144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020510543A Active JP7293194B2 (ja) | 2017-08-22 | 2018-08-22 | 癌治療のための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11529338B2 (https=) |
| EP (1) | EP3672582B1 (https=) |
| JP (1) | JP7293194B2 (https=) |
| CN (1) | CN111182894A (https=) |
| AU (1) | AU2018321950A1 (https=) |
| CA (1) | CA3073669A1 (https=) |
| IL (1) | IL272782A (https=) |
| WO (1) | WO2019040647A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10927070B2 (en) * | 2016-06-09 | 2021-02-23 | Cedars-Sinai Medical Center | Compositions and methods for treating cancer |
| CN114727993B (zh) * | 2019-10-07 | 2025-11-14 | D·E·萧尔研究有限责任公司 | 作为Kv1.3钾SHAKER通道阻断剂的芳基亚甲基杂环化合物 |
| PL447378A1 (pl) * | 2023-12-29 | 2025-06-30 | Uniwersytet Medyczny W Lublinie | Zastosowanie lepidylin w leczeniu nowotworu układu nerwowego. |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3270960A (en) | 1964-09-11 | 1966-09-06 | Sperry Rand Corp | Fluid sensor |
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| CA1294215C (en) | 1986-10-27 | 1992-01-14 | Ze'ev Shaked | Pharmaceutical compositions of recombinant beta-interferon and formulation processes |
| CA1292686C (en) | 1986-10-27 | 1991-12-03 | Ze'ev Shaked | Pharmaceutical compositions of recombinant interleukin-2 and formulation process |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6048877A (en) * | 1997-02-21 | 2000-04-11 | Bristol-Myers Squibb Company | Tetralone derivatives as antiarrhythmic agents |
| US6218367B1 (en) | 1998-09-15 | 2001-04-17 | Organomed Corporation | Paclitaxel-carbohydrate conjugates: design, synthesis and biological evaluations |
| US20060019256A1 (en) | 2003-06-09 | 2006-01-26 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| WO2007084992A2 (en) | 2006-01-19 | 2007-07-26 | The University Of Chicago | Prognosis and therapy predictive markers and methods of use |
| KR101810799B1 (ko) | 2008-02-01 | 2017-12-19 | 더 제너럴 하스피탈 코포레이션 | 의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도 |
| US20140056807A1 (en) | 2012-08-23 | 2014-02-27 | Cedars-Sinai Medical Center | Large oncosomes in human tumors and in circulation in patients with cancer |
| WO2014164730A2 (en) * | 2013-03-12 | 2014-10-09 | The Board Of Trustees Of The Leland Stanford Junior University | Modulation of cellular dna repair activity to intercept malignancy |
| EP2986326B1 (en) | 2013-04-15 | 2018-09-05 | Cedars-Sinai Medical Center | Methods for detecting cancer metastasis |
| US20170051149A1 (en) * | 2014-04-29 | 2017-02-23 | Ecole Normale Superieure De Lyon | Azoaryls as reversibly modulatable tubulin inhibitors |
| EP3151821A4 (en) | 2014-06-05 | 2017-12-13 | The University of Kansas | Marmelin analogs and methods of use in cancer treatment |
| WO2015197909A1 (en) * | 2014-06-27 | 2015-12-30 | Fermion Oy | Process for the preparation of a crystalline polymorph of 2-amino-3-hydroxy-n'-(2,3,4-trihydroxybenzyl)propanehydrazide (benserazide) hydrochloride |
| US11174518B2 (en) | 2015-10-05 | 2021-11-16 | Cedars-Sinai Medical Center | Method of classifying and diagnosing cancer |
| US10927070B2 (en) | 2016-06-09 | 2021-02-23 | Cedars-Sinai Medical Center | Compositions and methods for treating cancer |
-
2018
- 2018-08-22 EP EP18848878.7A patent/EP3672582B1/en active Active
- 2018-08-22 WO PCT/US2018/047569 patent/WO2019040647A1/en not_active Ceased
- 2018-08-22 CN CN201880061797.2A patent/CN111182894A/zh active Pending
- 2018-08-22 CA CA3073669A patent/CA3073669A1/en active Pending
- 2018-08-22 JP JP2020510543A patent/JP7293194B2/ja active Active
- 2018-08-22 AU AU2018321950A patent/AU2018321950A1/en not_active Abandoned
- 2018-08-22 US US16/640,902 patent/US11529338B2/en active Active
-
2020
- 2020-02-19 IL IL272782A patent/IL272782A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019504100A5 (https=) | ||
| EP3175853B1 (en) | Antineoplastic combinations of neratinib and capecitabine | |
| JP2023543299A5 (https=) | ||
| RU2021103727A (ru) | Фармацевтические композиции и способы борьбы с кардиотоксичностью, вызванной химиотерапией | |
| JP2015532295A5 (https=) | ||
| JP2020502259A5 (https=) | ||
| JP2020531495A5 (https=) | ||
| JP2017533922A5 (https=) | ||
| CN110769837A (zh) | 与五氮杂大环状环配合物的联合癌症免疫疗法 | |
| CN110167915A (zh) | 胺基硫醇类化合物及其制备方法和其在辐射防护中的应用 | |
| JP2019506392A5 (https=) | ||
| JP2018193302A (ja) | ペンタアザ大環状環複合体による組み合わせ癌免疫療法 | |
| EP3922251B1 (en) | Cancer immunotheraphy adjuvant | |
| EP4591940A3 (en) | Deoxy- cytidine derivatives for use in cancer therapies | |
| HK1219879A1 (zh) | 用於治疗癌症的包含mps-1激酶抑制剂和有丝分裂抑制剂的组合 | |
| AU2017283653A1 (en) | Porphyrin compounds and compositions useful for treating cancer | |
| JP2021511344A5 (https=) | ||
| JP2016523830A5 (https=) | ||
| JP2019511485A5 (https=) | ||
| JP2018511642A5 (https=) | ||
| EP4230205A1 (en) | Antitumor pharmaceutical composition and application thereof | |
| US20260041693A1 (en) | Combination therapy of cdk7 inhibitors with other anti-cancer therapies | |
| ES2859679T3 (es) | Compuestos, composición y usos de los mismos para tratar el cáncer | |
| JP2019525924A5 (https=) | ||
| ES2896051T3 (es) | Fármaco antitumoral que contiene un complejo de platino antitumoral y un potenciador del efecto antitumoral |